Director Marilyn Matz filed a Form 4 with the SEC on September 18, 2026, disclosing the sale of 400 shares of Teradyne, Inc. common stock on September 17, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Key Highlights
- Reporting person: Marilyn Matz, a director of Teradyne, Inc. (NASDAQ:TER)
- Shares sold: 400 shares of common stock disposed of (transaction code S) on September 17, 2026
- Sale price: $351.11 per share
- Remaining ownership: 13,840.675 shares beneficially owned directly following the transaction
- 10b5-1 plan: The sale was effected under a plan adopted by Matz on February 13, 2026, intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934
- Filing date: September 18, 2026, signed by Ryan E. Driscoll as attorney-in-fact
Marilyn Matz Share Sale Details: Teradyne Director Transaction
According to the Form 4 filing, Marilyn Matz, identified as a director of Teradyne, Inc., disposed of 400 shares of Teradyne common stock on September 17, 2026, at a price of $351.11 per share. The transaction is recorded in Table I as a sale (code "S") of non-derivative securities, with the shares classified as directly owned.
The filing discloses that the transaction was made pursuant to a sales plan adopted by Matz on February 13, 2026, and the filing notes the plan was "intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934." The Form 4 checkbox confirms the transaction was made pursuant to a contract, instruction, or written plan satisfying the affirmative defense conditions of Rule 10b5-1(c). Following the reported transaction, the filing states that Matz directly beneficially owns 13,840.675 shares of Teradyne common stock. No derivative securities transactions were reported in Table II of the filing.
The Form 4 was signed by Ryan E. Driscoll as attorney-in-fact on September 18, 2026, the same date it was filed with the SEC. No amendment to a prior Form 4 was indicated, and the filing was made by one reporting person.
What Was Disclosed
The filing reports a single open-market sale of 400 Teradyne common shares by Director Marilyn Matz at $351.11 per share on September 17, 2026, executed under a Rule 10b5-1 plan adopted February 13, 2026, leaving her with 13,840.675 directly held shares.



Please wait processing your request...